Resultado de búsqueda
David Earl Nichols (born December 23, 1944, Covington, Kentucky) is an American pharmacologist and medicinal chemist. Previously the Robert C. and Charlotte P. Anderson Distinguished Chair in Pharmacology at Purdue University, Nichols has worked in the field of psychoactive drugs since 1969.
David E. Nichols. Professor Emeritus of Pharmacology. E-mail: drdave@purdue.edu. Specialization: Medicinal and Bioorganic Chemistry; Molecular Pharmacology and Toxicology. Education. B.S. - 1969 - University of Cincinnati. Ph.D. - 1973 - University of Iowa. Postdoc - 1973-74 -University of Iowa. Research.
Nichols ha descrito su oficio como “diseñador de sondas moleculares de la función cerebral”; su papel como químico de drogas de diseño le ha permitido utilizar psicodélicos, conocidos e...
2017. Effects of Schedule I drug laws on neuroscience research and treatment innovation. DJ Nutt, LA King, DE Nichols. Nature Reviews Neuroscience 14 (8), 577-585. , 2013. 392. 2013. Effects of enantiomers of MDA, MDMA and related analogues on [3H] serotonin and [3H] dopamine release from superfused rat brain slices.
Psychedelics (serotonergic hallucinogens) are powerful psychoactive substances that alter perception and mood and affect numerous cognitive processes. They are generally considered physiologically safe and do not lead to dependence or addiction.
David E Nichols 1. Affiliation. 1 Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, 27599, USA. drdave@purdue.edu. PMID: 32398764. DOI: 10.1038/s41429-020-0311-8. Abstract. Psilocybin (4-phosphoryloxy-N,N-dimethyltryptamine) is an indole-based secondary metabolite produced by numerous species of mushrooms.
Hallucinogens (psychedelics) are psychoactive substances that powerfully alter perception, mood, and a host of cognitive processes. They are considered physiologically safe and do not produce dependence or addiction.
